Canton Strategic Holdings (CNTN) Payables (2020 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Payables came in at $402311.0 in Q1 2026, down 63.74% YoY from $1.1 million in Q1 2025, and down 63.1% on a QoQ basis from $1.1 million in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Payables (2020 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 7 years of Payables data on file, last reported at $402311.0 in Q1 2026.
- Quarterly Payables fell 63.74% year-over-year to $402311.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $402311.0 (down 63.74% YoY) and the FY2025 annual result came in at $1.1 million, changed 0.06% from the prior year.
- Payables eased to $402311.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $1.1 million in Q2 2023 to a low of $349716.0 in Q2 2025.
- A 5-year average of $822240.7 and a median of $820371.0 in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables tumbled 66.57% — and 2023, when it jumped 112.11%.
- Tracing CNTN's Payables over 5 years: stood at $954505.0 in 2022, then fell by 4.81% to $908577.0 in 2023, then gained by 19.93% to $1.1 million in 2024, then climbed by 0.06% to $1.1 million in 2025, then plunged by 63.1% to $402311.0 in 2026.
- The last three Payables figures came in at $402311.0 (Q1 2026), $1.1 million (Q4 2025), and $820371.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 167.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 88.42 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 470.30 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 35.57 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | 916,244.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 916,244.00 |
| Mar 31, 2026 | 402,311.00 |
| Dec 31, 2025 | 521,201.00 |
| Sep 30, 2025 | 820,371.00 |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 783,839.00 |
| Jun 30, 2024 | 784,029.00 |
| Mar 31, 2024 | 993,244.00 |
| Dec 31, 2023 | 908,577.00 |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 718,990.00 |
| Dec 31, 2022 | 954,505.00 |
| Sep 30, 2022 | 536,838.00 |
| Jun 30, 2022 | 559,529.00 |
| Mar 31, 2022 | 797,455.00 |
| Dec 31, 2021 | 2.86 Mn |
| Dec 31, 2020 | 1.08 Mn |